A detailed history of Geneos Wealth Management Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 23 shares of AXSM stock, worth $2,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Holding current value
$2,086
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.93 - $95.84 $1,815 - $2,204
23 New
23 $2,000
Q1 2020

Sep 07, 2021

SELL
$41.2 - $101.31 $99,127 - $243,751
-2,406 Closed
0 $0
Q4 2019

Sep 07, 2021

BUY
$16.71 - $106.24 $40,204 - $255,613
2,406 New
2,406 $245,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.